[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100525746":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":10,"centralContacts":33,"locations":39,"responsibleParty":69,"collaborators":71,"id":75,"slug":10,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":10,"eligibilityCriteria":80,"healthyVolunteers":76,"sex":81,"minAge":82,"maxAge":10,"enrollmentInfo":83,"targetDuration":10,"studyType":86,"phases":87,"briefSummary":89,"conditions":90,"keywords":92,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"Abramson Cancer Center at Penn Medicine","OTHER",[8,13,18],{"label":9,"type":6,"description":10,"interventionNames":11},"Usual Care",null,[12],"Behavioral: Usual Care",{"label":14,"type":15,"description":10,"interventionNames":16},"In-Person LEF-SMP","EXPERIMENTAL",[17],"Behavioral: In-Person LEF-SMP",{"label":19,"type":15,"description":10,"interventionNames":20},"Telehealth LEF-SMP",[21],"Behavioral: Telehealth LEF-SMP",[23,27,30],{"type":24,"name":9,"description":25,"armGroupLabels":26,"otherNames":10},"BEHAVIORAL","Participants will conduct self-care activities prescribed by their treating lymphedema therapists.",[9],{"type":24,"name":14,"description":28,"armGroupLabels":29,"otherNames":10},"Participants will receive the in-person LEF-SMP intervention.",[14],{"type":24,"name":19,"description":31,"armGroupLabels":32,"otherNames":10},"Participants will receive the telehealth LEF-SMP intervention.",[19],[34],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":38},"Jie Deng, PhD","CONTACT","2155732393","jiedeng@nursing.upenn.edu",[40,56],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"University of Pennsylvania","RECRUITING","Philadelphia","Pennsylvania","19104","United States",{"type":48,"coordinates":49},"Point",[50,51],-75.16362,39.95238,{"lat":51,"lon":50},[54],{"name":35,"role":36,"phone":55,"phoneExt":10,"email":38},"215-573-2393",{"facility":57,"status":42,"city":58,"state":59,"zip":60,"country":46,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Barbara Murphy","Nashville","Tennessee","37232",{"type":48,"coordinates":62},[63,64],-86.78444,36.16589,{"lat":64,"lon":63},[67],{"name":68,"role":36,"phone":10,"phoneExt":10,"email":10},"Barbara Murphy, MD",{"type":70,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[72],{"name":73,"class":74},"United States Department of Defense","FED","100525746",false,"NCT06125743","Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]","Promoting Self-Management in Head and Neck Cancer Survivors With Lymphedema and Fibrosis [PROMISE Trial]","Inclusion Criteria:\n\n* \\>18 years of age\n* Post HNC primary treatment\n* No evidence of cancer (NED)\n* Completion of initial lymphedema therapy for head and neck lymphedema\n* Unable to obtain lymphedema therapy due to barriers noted above\n* History of lymphedema on the face and neck, with or without fibrosis\n* Ability to understand English in order to complete questionnaires\n* Ability to perform self-care activities for LEF management\n* Ability to provide informed consent\n* Having an electronic device (a computer, tablet, iPad, or smartphone) and internet access at home\n* A valid email address\n\nExclusion Criteria:\n\n* Recurrent or metastatic cancer\n* Any other active cancer\n* Acute infection\n* Acute congestive heart failure\n* Acute renal failure\n* Cardiac or pulmonary edema\n* Sensitive carotid sinus\n* Severe carotid blockage\n* Uncontrolled hypertension\n* Venous thrombosis\n* Pregnant people\n* Incarcerated patients","ALL","18 Years",{"count":84,"type":85},204,"ESTIMATED","INTERVENTIONAL",[88],"NA","The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.",[91],"Lymphedema of the Head and Neck",[93,94,95,96,97],"Lymphedema","Fibrosis","Head and Neck Cancer","Survivorship","Self-Management","2025-08-09",{"date":100,"type":101},"2025-08-14","ACTUAL",{"date":103,"type":101},"2024-03-29",{"date":105,"type":85},"2026-08-31",{"name":5,"class":6},2]